ATE126221T1 - Thiazolidinverbindeungen, deren herstellung und therapeutische verwendung. - Google Patents
Thiazolidinverbindeungen, deren herstellung und therapeutische verwendung.Info
- Publication number
- ATE126221T1 ATE126221T1 AT92311813T AT92311813T ATE126221T1 AT E126221 T1 ATE126221 T1 AT E126221T1 AT 92311813 T AT92311813 T AT 92311813T AT 92311813 T AT92311813 T AT 92311813T AT E126221 T1 ATE126221 T1 AT E126221T1
- Authority
- AT
- Austria
- Prior art keywords
- alkyl
- hydrogen
- preparation
- therapeutic use
- optionally substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/34—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP34457191 | 1991-12-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE126221T1 true ATE126221T1 (de) | 1995-08-15 |
Family
ID=18370304
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT92311813T ATE126221T1 (de) | 1991-12-26 | 1992-12-24 | Thiazolidinverbindeungen, deren herstellung und therapeutische verwendung. |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP0549365B1 (de) |
| JP (1) | JP2833949B2 (de) |
| CN (1) | CN1032751C (de) |
| AT (1) | ATE126221T1 (de) |
| AU (1) | AU654223B2 (de) |
| CA (1) | CA2086277A1 (de) |
| CZ (1) | CZ389792A3 (de) |
| DE (1) | DE69204041T2 (de) |
| DK (1) | DK0549365T3 (de) |
| ES (1) | ES2078671T3 (de) |
| FI (1) | FI925849A (de) |
| GR (1) | GR3017632T3 (de) |
| HK (1) | HK196095A (de) |
| HU (1) | HU215450B (de) |
| IL (1) | IL104238A (de) |
| MX (1) | MX9207595A (de) |
| NO (1) | NO302471B1 (de) |
| NZ (1) | NZ245612A (de) |
| RU (1) | RU2095354C1 (de) |
| TW (1) | TW211007B (de) |
| ZA (1) | ZA9210021B (de) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO302519B1 (no) * | 1991-12-26 | 1998-03-16 | Sankyo Co | Tiazolidinforbindelser som inneholder en kinongruppe, og farmasöytisk preparat |
| EP0783888A1 (de) * | 1995-12-26 | 1997-07-16 | Sankyo Company Limited | Verwendung von Troglitazone und verwandten Thiazolidinedionen zur Herstellung eines Medikaments für die Behandlung und Vorbeugung der Osteoporose |
| US6331633B1 (en) * | 1998-05-08 | 2001-12-18 | Calyx Therapeutics Inc. | Heterocyclic analogs of diphenylethylene compounds |
| US6620830B2 (en) | 2000-04-21 | 2003-09-16 | Pfizer, Inc. | Thyroid receptor ligands |
| DE60115132T2 (de) * | 2000-04-21 | 2006-07-06 | Pfizer Products Inc., Groton | Thyroid-Rezeptorliganden |
| US6768008B2 (en) | 2000-04-24 | 2004-07-27 | Aryx Therapeutics | Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis |
| AU2001259130A1 (en) * | 2000-04-24 | 2001-11-07 | Aryx Therapeutics | Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis |
| US6680387B2 (en) | 2000-04-24 | 2004-01-20 | Aryx Therapeutics | Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis |
| JP2003040877A (ja) * | 2001-07-24 | 2003-02-13 | Sumika Fine Chemicals Co Ltd | ５−［６−（２−フルオロベンジルオキシ）−２−ナフチル］メチル−２，４−チアゾリジンジオンの製造方法及びその精製方法 |
| ES2397944T3 (es) | 2006-03-16 | 2013-03-12 | Metabolic Solutions Development Company Llc | Análogos de tiazolidindiona |
| ES2388555T3 (es) | 2006-03-16 | 2012-10-16 | Metabolic Solutions Development Company Llc | Análogos de tiazolidindiona |
| ES2398313T3 (es) * | 2007-09-14 | 2013-03-15 | Metabolic Solutions Development Company Llc | 5-(4-(2-(3-metoxifenil)-2-oxoetoxi)bencil)tiazolidin-2,4-diona para uso en el tratamiento de la diabetes |
| US8304441B2 (en) | 2007-09-14 | 2012-11-06 | Metabolic Solutions Development Company, Llc | Thiazolidinedione analogues for the treatment of metabolic diseases |
| KR102029611B1 (ko) | 2009-12-15 | 2019-10-07 | 씨리우스 테라퓨틱스, 엘엘씨 | 대사성 질환의 치료를 위한 ｐｐａｒ 절약형 티아졸리딘디온염 |
| AU2011242956B2 (en) * | 2010-04-19 | 2015-01-22 | Cirius Therapeutics, Inc. | Novel synthesis for thiazolidinedione compounds |
| EP2560615A1 (de) * | 2010-04-21 | 2013-02-27 | Metabolic Solutions Development Company LLC | Thiazolidindion-analoga |
| NZ606574A (en) | 2010-08-10 | 2015-02-27 | Metabolic Solutions Dev Co Llc | Novel synthesis for thiazolidinedione compounds |
| CN115433144B (zh) * | 2022-10-09 | 2023-09-19 | 燃点(南京)生物医药科技有限公司 | 一种脂肪酸酯类化合物及其制备方法和应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5522636A (en) * | 1978-08-04 | 1980-02-18 | Takeda Chem Ind Ltd | Thiazoliding derivative |
| JPS6051189A (ja) * | 1983-08-30 | 1985-03-22 | Sankyo Co Ltd | チアゾリジン誘導体およびその製造法 |
| JPH06779B2 (ja) * | 1985-06-10 | 1994-01-05 | 武田薬品工業株式会社 | チアゾリジオン誘導体およびそれを含んでなる医薬組成物 |
| US5143930A (en) * | 1990-02-07 | 1992-09-01 | Sankyo Company, Limited | Thiazolidine derivatives with anti-diabetic activity, their preparation and their use |
| NO302519B1 (no) * | 1991-12-26 | 1998-03-16 | Sankyo Co | Tiazolidinforbindelser som inneholder en kinongruppe, og farmasöytisk preparat |
-
1992
- 1992-12-22 NO NO924964A patent/NO302471B1/no unknown
- 1992-12-23 ZA ZA9210021A patent/ZA9210021B/xx unknown
- 1992-12-23 NZ NZ245612A patent/NZ245612A/en unknown
- 1992-12-23 FI FI925849A patent/FI925849A/fi not_active Application Discontinuation
- 1992-12-23 HU HUP9204130A patent/HU215450B/hu not_active IP Right Cessation
- 1992-12-24 DE DE69204041T patent/DE69204041T2/de not_active Expired - Fee Related
- 1992-12-24 TW TW081110354A patent/TW211007B/zh active
- 1992-12-24 CA CA002086277A patent/CA2086277A1/en not_active Abandoned
- 1992-12-24 EP EP92311813A patent/EP0549365B1/de not_active Expired - Lifetime
- 1992-12-24 AU AU30431/92A patent/AU654223B2/en not_active Ceased
- 1992-12-24 DK DK92311813.7T patent/DK0549365T3/da active
- 1992-12-24 AT AT92311813T patent/ATE126221T1/de not_active IP Right Cessation
- 1992-12-24 ES ES92311813T patent/ES2078671T3/es not_active Expired - Lifetime
- 1992-12-25 RU RU9292016231A patent/RU2095354C1/ru active
- 1992-12-25 JP JP4346122A patent/JP2833949B2/ja not_active Expired - Fee Related
- 1992-12-25 IL IL10423892A patent/IL104238A/en not_active IP Right Cessation
- 1992-12-26 CN CN92115234A patent/CN1032751C/zh not_active Expired - Fee Related
- 1992-12-28 MX MX9207595A patent/MX9207595A/es not_active IP Right Cessation
- 1992-12-28 CZ CS923897A patent/CZ389792A3/cs unknown
-
1995
- 1995-10-04 GR GR950402745T patent/GR3017632T3/el unknown
- 1995-12-28 HK HK196095A patent/HK196095A/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ES2078671T3 (es) | 1995-12-16 |
| AU654223B2 (en) | 1994-10-27 |
| IL104238A (en) | 1996-10-31 |
| CA2086277A1 (en) | 1993-06-27 |
| HK196095A (en) | 1996-01-05 |
| FI925849A0 (fi) | 1992-12-23 |
| MX9207595A (es) | 1994-06-30 |
| DE69204041D1 (de) | 1995-09-14 |
| NO924964D0 (no) | 1992-12-22 |
| RU2095354C1 (ru) | 1997-11-10 |
| TW211007B (de) | 1993-08-11 |
| NZ245612A (en) | 1994-06-27 |
| EP0549365A1 (de) | 1993-06-30 |
| FI925849A (fi) | 1993-06-27 |
| NO924964L (no) | 1993-06-28 |
| ZA9210021B (en) | 1993-07-02 |
| JPH05239041A (ja) | 1993-09-17 |
| JP2833949B2 (ja) | 1998-12-09 |
| EP0549365B1 (de) | 1995-08-09 |
| DE69204041T2 (de) | 1996-03-28 |
| NO302471B1 (no) | 1998-03-09 |
| DK0549365T3 (da) | 1995-12-18 |
| HU9204130D0 (en) | 1993-04-28 |
| HUT67788A (en) | 1995-04-28 |
| GR3017632T3 (en) | 1996-01-31 |
| CZ389792A3 (en) | 1994-01-19 |
| CN1074680A (zh) | 1993-07-28 |
| HU215450B (hu) | 1999-04-28 |
| AU3043192A (en) | 1993-07-01 |
| CN1032751C (zh) | 1996-09-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE126221T1 (de) | Thiazolidinverbindeungen, deren herstellung und therapeutische verwendung. | |
| DE69728544D1 (de) | Totalsynthese von acylfulvenen mit antitumorwirkung | |
| ATE165092T1 (de) | Thiazolidinederivate, die eine quinone-gruppe enthalten, ihre herstellung und therapeutische anwendung | |
| NO880995D0 (no) | Nye 5-alkoxy-2,4-diaminoalkylbenzener saavel som haarfarvemiddel med 5-alkoxy-2,4-diamino-alkylbenzen. | |
| RU92016231A (ru) | Тиазолидиновые соединения, способ их получения, фармацевтическая композиция и способ лечения | |
| RU92016230A (ru) | Тиазолидиновые соединения, фармацевтическая композиция, способ лечения и способы получения соединений | |
| ATE97899T1 (de) | 1,8-benzonaphthyridinderivate, ihre herstellung und diese enthaltende zusammensetzungen. | |
| ATE59844T1 (de) | Indolcarboxamidderivate, ihre salze, verfahren und zwischenprodukte, anwendung als heilmittel und zusammensetzungen die sie enthalten. | |
| FI20021652A (fi) | Tratsodonin alkyylijohdannaisten valmistuksessa käyttökelpoisia välituotteita | |
| ATE98961T1 (de) | 1,8-benzonaphthyridinderivate und ihre herstellung. | |
| DE69005318D1 (de) | 1,8-Benzonaphthyridinderivate, ihre Herstellung und diese enthaltende Zusammensetzungen. | |
| GR3008034T3 (de) | ||
| ATE126504T1 (de) | 1-phenoxycarbonyl-2-pyrrolidon-derivate und nootrope wirkstoffe. | |
| ATE12645T1 (de) | Phenylethylthiazolderivate, ihre herstellung und ihre anwendung in der therapeutik. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |